New Study Reveals Potential Link between Growth Hormone and Alzheimer's Disease
A recent study has raised concerns about the potential transmission of Alzheimer's disease through a now-banned growth hormone that was administered to short children in the United States and the United Kingdom between the 1960s and 1980s. The study, conducted by researchers at the University of California San Francisco and a London-based medical group, suggests that some individuals who received this hormone later developed Alzheimer's disease at a relatively young age.
